Form D · Pharmaceuticals
EYE-Pharma LLC
Little Rock, AR · CIK 0001597998
Offering snapshot reported Feb 5, 2014 · SEC filing
- Reported sold
- $146K Offering amount: $3M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jan 29, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 5, 2014 | Initial | $145,500 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-211349
Source: Form D, filed Feb 5, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tom Fitzgerald | Executive |
| Dr. Joe Fix | Director, Executive |
| Michael Geranen | Director, Executive |
| Dr. Sunil Gupta | Director, Executive |
| Dr. James K. Hendren | Director |
| Brett Matthews | Director, Executive |
| Dr. Shirish Shah | Executive |
| Terrence L. Shockley | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4301 West Markham Street #831
Little Rock, AR, 72205
Little Rock, AR, 72205